Anti-Cardiolipin Screen

Product Description

Indirect solid phase enzyme immunoassay (ELISA) for the simultaneous determination of IgG, IgM and IgA class autoantibodies against cardiolipin in human serum or plasma. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of an increased risk of thrombosis in patients with Systemic Lupus Erythematosus (SLE) or lupuslike disorders.

List Price: $214.00

SKU:

ORG 515S

Bulk Discounts for Anti-Cardiolipin Screen

Below are the available bulk discount rates for each individual item when you purchase a certain amount

Buy 5 - 20 and pay only $203.30 each
Buy 21 - 30 and pay only $192.60 each
Buy 31 - 50 and pay only $181.90 each
Buy 51 - 9999 and pay only $171.20 each

Overview
Description

Product Description

Other Details

Assay Description:

30 min. incubation (RT) + 15 min. (RT) + 15 min. (RT) + 5 min. (RT) = 1 hour, 5 min. total incubation time.

Catalog number:

ORG 515S

configuration:

96 Determinations, 12x8 removable strips

controls:

Negative control, positive control, strong positive control, ready to use.

design:

Indirect solid phase enzyme immunometric assay (ELISA).

FDA Status:

510(k) cleared.

MSDS:

Click for MSDS

notes:

The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.

Protocol:

Click for Protocol

Sample types:

Human serum or plasma.

Sample volume:

100 μL of properly diluted (1:100) unknown / determination.

standards:

Cut-off control, ready to use.

Standard range:

Evaluation of the Anti-Cardiolipin screen test is carried out by direct comparison of the optical density of each unknown with the optical density of the cut-off control.

storage:

2 - 8 °C

sensitivity:

Please see protocol for assay-specific performance characteristics.

Species:

Human

OUR ASSAY KIT CATEGORIES